The cancer therapy developer has raised $80m in a mezzanine round that came almost 18 months after its series C, with Lilly Asia Ventures and SR One backing both rounds.

Johnson & Johnson Innovation – JJDC was among the investors in CuraSen Therapeutics' $54.5m series A round, which was led by New Leaf Venture Partners.

Smart projector and TV manufacturer Holatek has attracted $86.5m in series D funding from a consortium led by Alibaba that featured the newly unveiled 36Kr Fund.

The eSports team manager has added series B funding to a 2017 series A backed by WWE, FunPlus, Beverly Hills Sports Council and UTA Ventures.

Amgen has invested $66m in genetic sequencing system provider Oxford Nanopore, increasing its latest funding round to $206m.

Source Code Capital and an unnamed sovereign wealth fund have provided capital for Edianzu, the IT equipment supplier backed by Lakala.

Oxford Nanopore has secured $66m from Amgen, after the latter’s subsidiary Decode Genetics used the spinout’s technology to sequence hundreds of human genomes.

The two-wheeled vehicle producer is acquiring a stake greater than 25% in electric scooter developer and new strategic partner Twenty Two.

The cell biology technology developer, based on UC Berkeley research, took its total funding to almost $220m in a Nikon-led round that included fellow strategic backer Varian.

The cell biology technology developer took its total funding to almost $220m in a Nikon-led round that included fellow strategic backer Varian.